How AI Is Aiming at the Bad Math of Drug Development

Robert Marcus
Nov 29, 2021

Related news

Nov 9
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Accenture (ACN) Announces Strategic Investment in Geneyx

Nov 2
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Four major impacts of artificial intelligence on healthcare

Dec 9
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Pharma giant collabs with CMU in AI academy launch

May 10
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Exscientia : Announces Closing of $510.4 Million Aggregate Financing, Consisting of $350.4 Million Upsized Initial Public Offering With Full Exercise of Underwriters' Option to Purchase Additional ADSs and $160.0 Million Concurrent Private Placement

Dec 5
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Analyst shares the impact of ML applications in LS

Nov 27
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

The Bright New Age of Venture Capital

Jan 25
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Instadeep raises $100M for AI decision-making tools

Sep 20
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Jeito extends global reach in oversubscribed $625M venture fund

Dec 2
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

VC investors share AI's impact on LS industries

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Morocco’s Mohammed VI Polytechnic University and ALPHA10X Sign Research and Development Partnership Agreement

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Innovative AI-powered Search and Discovery Platform; Interview With Robert Marcus

Feb 1
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X Emerges from Stealth With $9.4 Million In Seed Funding